Document is current
Any future updates will be listed below
-
Authors
Patel, Vishal https://orcid.org/0000-0003-2875-4659
Chung, Eun Ji https://orcid.org/0000-0002-7726-5555
- License Information
-
More Information
Article History
First Online: 26 November 2025
Competing interests
: V.P. has served as a scientific consultant for Otsuka Pharmaceuticals, Maze Therapeutics, Travere Therapeutics and Regulus Therapeutics, and serves as the chair of the Scientific Advisory Panel for the PKD Foundation. V.P.’s laboratory also has a sponsored research agreement with Regulus Therapeutics, a Novartis company, which is unrelated to this work. V.P. has licensed patents (US11168325B2) involving anti-miR-17 for the treatment of ADPKD, which is unrelated to the current manuscript. E.J.C. serves as chief scientific officer for Silver Spur Therapeutics, which is unrelated to the current manuscript.
